S&P 500 Futures
(-0.62%) 5 291.75 points
Dow Jones Futures
(-0.55%) 38 731 points
Nasdaq Futures
(-0.66%) 18 816 points
Oil
(0.88%) $80.53
Gas
(-0.39%) $2.58
Gold
(-0.46%) $2 345.60
Silver
(0.21%) $32.21
Platinum
(-0.75%) $1 058.80
USD/EUR
(0.09%) $0.922
USD/NOK
(0.00%) $10.50
USD/GBP
(0.03%) $0.784
USD/RUB
(0.78%) $89.26

Q1/2024

Generated By Getagraph.com: 2024-03-31

Encompass Health Corp [EHC] -1.21% $ 83.47
Birža: NYSE Sektorius: Healthcare Pramonė: Medical - Care Facilities

Encompass Health Corp: Q1 2024 Financial Report Summary

This document provides a summary of the financial results for Encompass Health Corp (NYSE: EHC) for the first quarter of the calendar year 2024.

Company Overview

Encompass Health Corp, listed on the NYSE under the ticker symbol EHC, operates within the Healthcare sector, focusing on Medical Care Facilities. For the first quarter of 2024, the company has reported strong financial results demonstrating its operational efficiency and stability in the market.

Financial Performance

In Q1 2024, Encompass Health reported a revenue of $1.32 billion, reflecting a slight decrease from previous quarters. The company achieved a net income of $112.5 million, which translates to a basic earnings per share (EPS) of $1.13 and a diluted EPS of $1.10. Encompass Health maintained a gross profit of $386.5 million with a gross profit margin of 29.37%, underscoring consistent profitability in its core operations.

The operating income of the company was noted at $140.1 million, reflecting an operating margin of 10.65%. This indicates effective management of operating costs. Additionally, the EBITDA was reported at $256.3 million, resulting in an EBITDA margin of 19.48%, which emphasizes the company's operational efficiency.

The total assets were valued at $6.23 billion, with net debt at approximately $2.79 billion, showcasing a stable financial structure and manageable debt levels. Total equity was reported at $2.36 billion, indicating a strong balance sheet.

Market Data and Ratios

As of this report, the market capitalization of Encompass Health stands at $8.29 billion. The company holds an Altman Z-score of 2.54, suggesting a moderate risk of bankruptcy, and a Piotroski score of 7, indicating robust financial health.

Comparatively, Encompass Health has shown excellence with a trailing twelve months (TTM) gross profit margin of 75.77% and an operating profit margin of 12.61%. Its net profit margin TTM was recorded at 7.33%, aligning favorably within industry averages and benchmarks.

Conclusion

The Q1 2024 financial results for Encompass Health Corp reflect a financially stable entity with proficient management and effective operational strategies. With a solid position in the competitive medical care facilities sector, attention to cost management and operational efficiencies will further propel profitability in subsequent quarters.

For more in-depth financial figures and analyses, stakeholders are encouraged to review the comprehensive financial statements and disclosures available on the SEC website.

Revenues Q1 - 2024

Revenue Gross Profit Operating Expenses Interest Expense EBITDA Net Income EPS
$1.32B $257.70M $50.20M $35.20M $277.80M $112.50M $1.120

Balance Q1 - 2024

Net IncomeDepreciation and AmortizationStock Based CompensationChange in Working CapitalNet Cash Provided by Operating ActivitiesCapital ExpenditureFree Cash Flow
$113.00M$70.30M$9.30M$-1.60M$238.80M$-139.40M$99.40M

Other Reports

Symbol Period Year Title
OOMA Q1 2025 Ooma Inc Q1 2025 Financial Results
MAPSW Q4 2023 Q1 2024 Financial Results for WM Technology, Inc.
MAPS Q4 2023 WM Technology, Inc. (MAPS) Q1 2024 Financial Results
STEP Q4 2024 StepStone Group Inc. (NASDAQ: STEP) Fiscal Q4 2024 Financial Results
SNPS Q2 2024 Synopsys Inc. Q2 Fiscal Year 2024 Financial Report
BYFC Q1 2024 Q1 2024 Financial Results for Broadway Financial Corp (BYFC)
LGF-A Q4 2024 FY 2024 Financial Results - Lions Gate Entertainment Corp (LGF-A)
MOD Q4 2024 Modine Manufacturing Co. Fourth Quarter and Fiscal Year 2024 Financial Report
LPG Q4 2023 Dorian LPG Ltd. Q4 2023 Financial Report
EA Q4 2024 Electronic Arts Inc. Reports Fourth Quarter and Fiscal Year End 2024 Financial Results
TTWO FY 2024 Take-Two Interactive Software Inc. Q4 and Fiscal Year 2024 Financial Results
AGYS Q4 2023 Agilysys Inc Fiscal Year 2023 Fourth Quarter and Full Year Financial Results
TARO Q4 2024 Taro Pharmaceutical Industries Ltd - FY2024 Financial Results
HAE Q4 2024 Haemonetics Corporation Q4 2024 Financial Results
MESA Q1 2024 Q1 2024 Financial Results: Mesa Air Group Inc (NASDAQ: MESA)
HAE FY 2024 Haemonetics Corporation Q4 2024 Financial Report
ROLLP FY 2023 ROLLP Financial Results for Fiscal Year 2023
ROLL FY 2023 RBC Bearings Q1 Fiscal Year 2023 Financial Report
RBCP FY 2023 RBCP Financial Results for Fiscal Year 2023
RBC FY 2023 RBC Bearings Fiscal 2024 Fourth Quarter Earnings Report
FLEX Q4 2024 Flex Ltd. Fourth Quarter Fiscal 2024 Financial Report
AREN Q1 2024 Q1 2024 Financial Results - The Arena Group Holdings, Inc. (AREN)
CPA Q1 2024 Copa Holdings SA Q1 2024 Financial Results
FFNTF Q1 2024 Q1 2024 Financial Results for 4Front Ventures Corp.
FFNTF Q1 2024 Q1 2024 Financial Results of 4Front Ventures Corp. (FFNTF)
CVU Q1 2024 Financial Report for Q1 2024 - CPI Aerostructures Inc (Ticker: CVU)
NVTSW Q1 2024 Q1 2024 Financial Results - Navitas Semiconductor Corporation (NASDAQ: NVTSW)
NVTS Q1 2024 Navitas Semiconductor Corporation Q1 2024 Financial Results
BATL Q1 2024 Q1 2024 Financial Results: Battalion Oil Corp (AMEX: BATL)
PBH FY 2024 Prestige Consumer Healthcare Inc Q4 2024 Financial Results
CTM Q1 2024 CTM Q1 2024 Financial Results
XGN Q1 2024 Exagen, Inc. First Quarter 2024 Financial Report
CMGR Q1 2024 Clubhouse Media Group, Inc. Q1 2024 Financial Results
LEAT Q1 2024 Leatt Corporation Reports Q1 2024 Financial Results
HTBK Q1 2024 Heritage Commerce Corp Q1 2024 Financial Results
CTMX Q1 2024 Q1 2024 Financial Performance Analysis of CytomX Therapeutics Inc.
PGR Q1 2024 Q1 2024 Financial Results for Progressive Corp (PGR)
ZH FY 2023 Zhihu Inc. Full Year 2023 Financial Performance Review
ALLE Q1 2024 Allegion PLC Q1 2024 Financial Performance Report
NDAQ Q1 2024 Nasdaq Inc: Q1 2024 Financial Performance Overview
NBRWF Q1 2024 Q1 2024 Financial Results Analysis for Unspecified Company (Ticker: NBRWF)
EHC Q1 2024 Encompass Health Corp: Q1 2024 Financial Report Summary
STZ Q4 2024 Constellation Brands Inc Comprehensive Financial Report for Fiscal Year 2024
BFI FY 2023 BurgerFi International, Inc. Fiscal Year 2023 Fourth Quarter Financial Results
ASPI FY 2023 Annual Financial Report for Aspire Real Estate Investors, Inc. for Fiscal Year 2023
HTCR FY 2023 HeartCore Enterprises, Inc. - Fiscal Year 2023 Financial Performance Summary
IVA FY 2023 Inventiva S.A. Reports Fiscal Year 2023 Financial Results
REX Q4 2023 REX American Resources Corp Fiscal Year 2023 Financial Report
BAMR Q4 2023 BAMR Q4 2023 Financial Results Overview
KRNT FY 2023 Kornit Digital Ltd Q4 and Full-Year 2023 Financial Results